Acrivon Therapeutics, Inc. ACRV
2.10
(0.02)
(0.94%)
as of 25 Sep
- Market cap
- $90.9M
- P/E
- 0.0×
Follow ACRV
Insider Buys
alert about insiders buying in the last 12 month
| Older periods | Sep '25 | Dec '25 | Mar '26 | Jun '26 | |
|---|---|---|---|---|---|
Current Ratio |
+8 more quarters Free account |
8.75 | 7.69 | 8.98 | 7.99 |
Net Debt/EBITDA |
6.67 | 6.04 | 5.05 | 4.94 | |
Debt/Assets |
0.00% | 0.00% | 0.00% | 0.00% | |
Debt/Equity |
0.00 | 0.00 | 0.00 | 0.00 | |
Asset Turnover |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF/Net income |
0.67 | 0.80 | 1.08 | 0.83 | |
Capex/Depreciation |
(2.85) | (0.45) | (0.03) | (0.19) | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Intangible Assets out of Total Assets |
0.00 | 0.00 | 0.00 | 0.00 | |
Share Based Compensation of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Free Cash Flow per Share |
(0.34) | (0.40) | (0.53) | (0.36) | |
Cash per Share |
3.35 | 3.08 | 2.52 | 2.15 | |
Shareholders Equity per Share |
3.34 | 2.92 | 2.47 | 2.07 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
3.34 | 2.92 | 2.47 | 2.07 | |
Free Cash Flow |
(13.18) | (15.46) | (20.55) | (14.95) | |
Working Capital |
115.47 | 104.78 | 88.17 | 80.05 | |
Capital Expenditures |
(0.90) | (0.22) | (0.01) | (0.09) | |
Net Current Asset Value |
113.67 | 103.24 | 86.90 | 79.07 | |
| Other line items | |||||
Quick Ratio |
8.68 | 7.57 | 8.84 | 7.86 | |
Revenue per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF per Share |
(0.32) | (0.40) | (0.53) | (0.36) | |
Capex per Share |
(0.02) | (0.01) | 0.00 | 0.00 | |
Average Payables |
1.25 | 1.52 | 2.43 | 1.01 | |
Average Assets |
179.99 | 163.15 | 142.09 | 128.84 | |
Average Common Equity |
162.75 | 144.65 | 127.95 | 114.85 | |
Capex to Sales |
0.00 | 0.00 | 0.00 | 0.00 | |
Net Profit Margin |
0.00% | 0.00% | 0.00% | 0.00% |
Columns are period end dates